Cilosol Adverse Reactions

>10%: Central nervous system: Headache (27% to 34%).
Gastrointestinal: Abnormal stools (12% to 15%), diarrhea (12% to 19%).
Respiratory: Rhinitis (7% to 12%).
Miscellaneous: Infection (10% to 14%).
2% to 10%: Cardiovascular: Peripheral edema (7% to 9%), palpitation (5% to 10%), tachycardia (4%).
Central nervous system: Dizziness (9% to 10%), vertigo (up to 3%).
Gastrointestinal: Dyspepsia (6%), nausea (6% to 7%), abdominal pain (4% to 5%), flatulence (2% to 3%).
Neuromuscular and skeletal: Back pain (6% to 7%), myalgia (2% to 3%).
Respiratory: Pharyngitis (7% to 10%), cough (3% to 4%).
<2% (Limited to important or life-threatening): Agran­ulocytosis, anemia, aplastic anemia, asthma, atrial fibrillation, atrial flutter, blindness, blood pressure increased, bursitis, cardiac arrest, cerebral infarc­tion/ischemia, cerebrovascular accident, chest pain, CHF, cholelithiasis, colitis, coronary stent thrombosis, cystitis, diabetes mellitus, duodenal ulcer, duodenitis, esophageal hemorrhage, esoph­agitis, extradural hematoma, gastrointestinal hemorrhage, gout, granulocytopenia, hemorrhage, hepatic dysfunction, hot flashes, hyperglycemia, hypotension, interstitial pneumonia, intracranial hemorrhage, jaundice, leukopenia, myocardial infarction/ischemia, neuralgia, nodal arrhythmia, pain, periodontal abscess, peptic ulcer, pneumonia, polycythemia, postural hypotension, pulmonary hemorrhage, pruritus, QT_c prolongation, rectal hemorrhage, retinal hemorrhage, retroperitoneal hemorrhage, Stevens-Johnson syndrome, subcutaneous hemorrhage, subdural hematoma, supraven­tricular tachycardia, syncope, thrombocytopenia, thrombosis, torsade de pointes, uric acid increased, ventricular tachycardia.